4-Butylresorcinol
Chemical compound
From Wikipedia, the free encyclopedia
4-Butylresorcinol, sometimes called 4-n-butylresorcinol, is a chemical used to treat hyperpigmentation of the epidermis. Hyperpigmentation is believed to be related to the enzyme tyrosinase which produces melanin. Among several chemicals known to inhibit tyrosinase production, such as hydroquinone, arbutin, and kojic acid, 4-butylresorcinol has been found to be the most powerful inhibitor by IC50,[3] but the mode of inhibition is reversible.[4] 4-Butylresorcinol can be used in the synthesis of tetrahydrocannabutol.
| compound | in vitro IC50 | in vivo |
|---|---|---|
| arbutin | > 5000 | |
| hydroquinone | > 1000 | < 40 |
| kojic acid | 500 | |
| 4-n-butylresorcinol | 21 | 13.5 |
| Names | |
|---|---|
| Preferred IUPAC name
4-Butylbenzene-1,3-diol | |
| Other names
Rucinol, 4-n-Butylresorcinol | |
| Identifiers | |
3D model (JSmol) |
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.126.948 |
| EC Number |
|
| KEGG | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C10H14O2 | |
| Molar mass | 166.220 g·mol−1 |
| Hazards | |
| GHS labelling: | |
| Warning | |
| H302, H315, H319, H400 | |
| P264, P270, P273, P280, P301+P312, P302+P352, P305+P351+P338, P321, P330, P332+P313, P337+P313, P362, P391, P501 | |
| Lethal dose or concentration (LD, LC): | |
LD50 (median dose) |
500mg/kg (rat) [1] |
| Safety data sheet (SDS) | [2] |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
